LAVORGNA, SERENA

LAVORGNA, SERENA  

Dipartimento di Biomedicina e Prevenzione  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.03 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2009 A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. Careccia, S; Mainardi, S; Pelosi, A; Gurtner, A; Diverio, D; Riccioni, R; Testa, U; Pelosi, E; Piaggio, G; Sacchi, A; Lavorgna, S; LO COCO, F; Blandino, G; Levrero, M; Rizzo, Mg Articolo su rivista
1-gen-2019 Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations Mariotti, B; Meconi, F; Palmieri, R; De Bellis, E; Lavorgna, S; Ottone, T; Martini, V; Lo-Coco, F; Cicconi, L Articolo su rivista
1-gen-2013 Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups Riva, L; Ronchini, C; Bodini, M; LO COCO, F; Lavorgna, S; Ottone, T; Martinelli, G; Iacobucci, I; Tarella, C; Cignetti, A; Volorio, S; Bernard, L; Russo, A; Melloni, G; Luzi, L; Alcalay, M; Dellino, G; Pelicci, P Articolo su rivista
25-ago-2020 Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells Travaglini, S; Angelini, Df; Alfonso, V; Guerrera, G; Lavorgna, S; Divona, M; Nardozza, Am; Consalvo, Mi; Fabiani, E; De Bardi, M; Neri, B; Forghieri, F; Marchesi, F; Paterno, G; Cerretti, R; Barragan, E; Fiori, V; Dominici, S; Del Principe, Mi; Venditti, A; Battistini, L; Arcese, W; Lo-Coco, F; Voso, Mt; Ottone, T Articolo su rivista
17-mar-2022 Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Maurillo, L; Del Principe, M; Paterno, G; Irno-Consalvo, M; Ottone, T; Divona, M; Conti, C; Fraboni, D; Lavorgna, S; Arcese, W; Voso, Mt; Venditti, A Articolo su rivista
1-gen-2018 Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes Martinez-Losada, C; Serrano-Lopez, J; Serrano-Lopez, J; Noguera, Ni; Garza, E; Piredda, L; Lavorgna, S; Consalvo, Mai; Ottone, T; Alfonso, V; Peinado, Jr; Garcia-Ortiz, Mv; Morales-Ruiz, T; Jerez, A; Hurtado, Am; Montesinos, P; Cervera, J; Such, E; Ibanez, M; Sempere, A; Sanz, Ma; Lo-Coco, F; Sanchez-Garcia, J Articolo su rivista
1-gen-2018 Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy Iaccarino, L; Ottone, T; Hasan, S; Divona, M; Cicconi, L; Lavorgna, S; Alfonso, V; Basso, G; Barragán, E; Bocchia, M; Rego, E; Grimwade, D; Voso, Mt; LO COCO, F Articolo su rivista
1-gen-2007 Diagnostic refinement of chronic myeloproliferative disorders and thrombocytoses of unknown origin by multiple RT-PCR and capillary electrophoresis of BCR-ABL rearrangements and JAK2 (V617F) mutation Ammatuna, E; LO COCO, F; Ottone, T; Zaza, S; Lavorgna, S; Grillo, R; Curzi, P; Panetta, P; Federici, G; Amadori, S Articolo su rivista
16-gen-2019 Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia Alfonso, V; Iaccarino, L; Ottone, T; Cicconi, L; Lavorgna, S; Divona, M; Cairoli, R; Cristiano, A; Ciardi, C; Travaglini, S; Falconi, G; Hasan, Sk; Venditti, A; Arcese, W; Voso, Mt; Lo-Coco, F Articolo su rivista
1-gen-2022 ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Capria, S; Maurillo, L; Del Principe, Mi; Paterno, G; Irno Consalvo, Ma; Ottone, T; Lavorgna, S; Voso, Mt; Fazi, P; Vignetti, M; Arcese, W; Venditti, A Articolo su rivista
1-gen-2014 Erratum: Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups (Blood Cancer Journal (2013) 3 (e147) DOI:10.1038/bcj.2013.46) Riva, L; Ronchini, C; Bodini, M; LO COCO, F; Lavorgna, S; Ottone, T; Martinelli, G; Iacobucci, I; Tarella, C; Cignetti, A; Volorio, S; Bernard, L; Russo, A; Melloni, G; Luzi, L; Alcalay, M; Dellino, G; Pelicci, P Articolo su rivista
19-set-2019 GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia Venditti, A; Piciocchi, A; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; de Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Mazza, P; Martelli, Mp; Cuneo, A; Albano, F; Fabbiano, F; Tafuri, A; Chierichini, A; Tieghi, A; Fracchiolla, Ns; Capelli, D; Foà, R; Alati, C; La Sala, E; Fazi, P; Vignetti, M; Maurillo, L; Buccisano, F; Del Principe, Mi; Irno-Consalvo, M; Ottone, T; Lavorgna, S; Voso, Mt; Lo-Coco, F; Arcese, W; Amadori, S Articolo su rivista
1-gen-2019 Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia Iaccarino, L; Divona, M; Ottone, T; Cicconi, L; Lavorgna, S; Ciardi, C; Alfonso, V; Travaglini, S; Facchini, L; Cimino, G; Di Bona, E; Voso, Mt; Lo-Coco, F Articolo su rivista
8-feb-2018 Longitudinal detection of DNMT3AR882Htranscripts in patients with acute myeloid leukemia Ottone, T; Alfonso, V; Iaccarino, L; Hasan, Sk; Mancini, M; Divona, M; Lavorgna, S; Cicconi, L; Panetta, P; Maurillo, L; Del Principe, Mi; Irno Consalvo, M; Franceschini, L; Angelini, Df; Battistini, L; Guerrera, G; DE BARDI, M; Fabiani, E; Falconi, G; Arcese, W; Amadori, S; Buccisano, F; Venditti, A; Voso, Mt; Lo-Coco, F Articolo su rivista
13-ott-2020 Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial Voso, Mt; Larson, Ra; Jones, D; Marcucci, G; Prior, T; Krauter, J; Heuser, M; Lavorgna, S; Nomdedeu, J; Geyer, Sm; Walker, A; Wei, Ah; Sierra, J; Sanz, Ma; Brandwein, Jm; de Witte, Tm; Jansen, Jh; Niederwieser, D; Appelbaum, Fr; Medeiros, Bc; Tallman, Ms; Schlenk, Rf; Ganser, A; Amadori, S; Cheng, Y; Chen, Y; Pallaud, C; Du, L; Piciocchi, A; Ehninger, G; Byrd, J; Thiede, C; Döhner, K; Stone, Rm; Döhner, H; Bloomfield, Cd; Lo-Coco, F Articolo su rivista
1-gen-2012 miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. Oncogene Pelosi, A; Careccia, S; Lulli, V; Romania, P; Marziali, G; Testa, U; Lavorgna, S; LO COCO, F; Petti, M; Calabretta, B; Levrero, M; Piaggio, G; Rizzo, M Articolo su rivista
1-gen-2019 MRD in AML: The Role of New Techniques Voso, Mt; Ottone, T; Lavorgna, S; Venditti, A; Maurillo, L; Lo-Coco, F; Buccisano, F Articolo su rivista
10-lug-2019 Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse Iaccarino, L; Ottone, T; Alfonso, V; Cicconi, L; Divona, M; Lavorgna, S; Travaglini, S; Ferrantini, A; Falconi, G; Baer, C; Usai, M; Forghieri, F; Venditti, A; Del Principe, Mi; Arcese, W; Voso, Mt; Haferlach, T; Lo-Coco, F Articolo su rivista
1-gen-2019 Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS) Fabiani, E; Calabrese, C; Niscola, P; Balleari, E; Molteni, A; Finelli, C; Falconi, G; Fenu, S; Fianchi, L; Criscuolo, M; Salvi, F; Lavorgna, S; Buccisano, F; Maurillo, L; Lo Coco, F; Cilloni, D; Voso, Mt Articolo su rivista
1-gen-2011 NPM1 gene deletions in myelodysplastic syndromes with 5q- and complex karyotype. Ammatuna, E; Panetta, P; Agirre, X; Ottone, T; Lavorgna, S; Calasanz, M; LO COCO, F Articolo su rivista